November 7, 2016 09:58 AM ESTUpdated 11:34 AM

Therapix Bio in the hunt for $12M micro IPO; Progenics bags $50M loan; Juno isn't going anywhere, for now

A low profile Israeli biotech named Therapix Biosciences is taking a flier on a micro IPO on NASDAQ. The biotech has done some preclinical work …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Ther­a­pix Bio in the hunt for $12M mi­cro IPO; Prog­en­ics bags $50M loan; Juno is­n't go­ing any­where, for now